Public Meeting of the Presidential Commission for the Study of Bioethical Issues, 48819 [2016-17620]
Download as PDF
<![CDATA[
Federal Register / Vol. 81, No. 143 / Tuesday, July 26, 2016 / Notices
We estimate the burden for the
preparation of each record to be .10
hours for a total burden of 2,400 hours.
We estimate that all processors
(15,000 processors) will maintain
records of the calibration of processmonitoring instruments and the
performing of any periodic end-product
and in-process testing (§ 123.8(d)) at 47
records per processor for a total of
705,000 records. We estimate the
burden for the preparation of each
record to be .10 hours for a total burden
of 70,500 hours.
We estimate that all processors
(15,000 processors) will maintain
sanitation control records (§ 123.11(c))
at 280 records per processor for a total
of 4,200,000 records. We estimate the
burden for the preparation of each
record to be .10 hours for a total burden
of 420,000 hours.
We estimate that all importers (4,100
importers) will maintain records that
verify that the fish and fishery products
they offer for import into the United
States were processed in accordance
with the HACCP and sanitation
provisions set forth in part 123
(§ 123.12(c)). We estimate that 80
records will be prepared per importer
for a total of 328,000 records. We
estimate the burden for the preparation
of each record to be .10 hours for a total
burden of 32,800 hours.
We estimate that 1 percent of all
importers (41 importers) will require
new written verification procedures to
verify compliance of imports
(§ 123.12(a)(2)). We estimate the burden
for preparing the new procedures to be
4 hours per importer for a total burden
of 164 hours.
Dated: July 19, 2016.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2016–17571 Filed 7–25–16; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Public Meeting of the Presidential
Commission for the Study of
Bioethical Issues
Presidential Commission for
the Study of Bioethical Issues, Office of
the Assistant Secretary for Health,
Office of the Secretary, Department of
Health and Human Services.
ACTION: Notice of meeting.
srobinson on DSK5SPTVN1PROD with NOTICES
AGENCY:
The Presidential Commission
for the Study of Bioethical Issues (the
Commission) will conduct its twentysixth meeting on August 31, 2016. At
this meeting, the Commission will
SUMMARY:
VerDate Sep<11>2014
20:28 Jul 25, 2016
Jkt 238001
reflect on the past, present, and future
impact of national bioethics advisory
bodies. Topics will include the history
of national bioethics advisory bodies
and their contributions to health policy,
perspectives about similar bodies
elsewhere, and discussion about what
the future holds for groups like the
Commission.
DATES: The meeting will take place
August 31, 2016, from 9 a.m. to
approximately 4 p.m.
ADDRESSES: Annenberg Public Policy
Center, 202 S. 36th St., Philadelphia, PA
19104.
FOR FURTHER INFORMATION CONTACT: Lisa
M. Lee, Executive Director, Presidential
Commission for the Study of Bioethical
Issues, 330 C Street SW., Suite L001,
Washington, DC 20201. Telephone:
202–795–7689. Email: Lisa.Lee@
bioethics.gov. Additional information
may be obtained at www.bioethics.gov.
SUPPLEMENTARY INFORMATION: Pursuant
to the Federal Advisory Committee Act
of 1972, Public Law 92–463, 5 U.S.C.
app. 2, notice is hereby given of the
twenty-sixth meeting of the
Commission. The meeting will be open
to the public with attendance limited to
space available. The meeting will also
be webcast at www.bioethics.gov.
Under authority of Executive Order
13521, dated November 24, 2009, the
President established the Commission.
The Commission is an expert panel of
not more than 13 members who are
drawn from the fields of bioethics,
science, medicine, technology,
engineering, law, philosophy, theology,
or other areas of the humanities or
social sciences. The Commission
advises the President on bioethical
issues arising from advances in
biomedicine and related areas of science
and technology. The Commission seeks
to identify and promote policies and
practices that ensure scientific research,
health care delivery, and technological
innovation are conducted in a socially
and ethically responsible manner.
The main agenda for the
Commission’s twenty-sixth meeting is to
reflect upon the role of national
bioethics advisory bodies, both in the
US and abroad, in the past, present, and
future.
The Commission welcomes input
from anyone wishing to provide public
comment on any issue before it.
Respectful consideration of opposing
views and active participation by
citizens in public exchange of ideas
enhances overall public understanding
of the issues at hand and conclusions
reached by the Commission. The
Commission is particularly interested in
receiving comments and questions
PO 00000
Frm 00084
Fmt 4703
Sfmt 4703
48819
during the meeting that are responsive
to specific sessions. Written comments
will be accepted in advance, during, and
after the meeting and are especially
welcome. Comments will be publicly
available, including any personally
identifiable or confidential business
information that they contain. Trade
secrets should not be submitted.
Written comments will be accepted by
email to info@bioethics.gov, or by mail
to the following address: Public
Commentary, Presidential Commission
for the Study of Bioethical Issues, 330
C Street SW., Suite L001, Washington,
DC 20201. To accommodate as many
individuals as possible, the time for
each question or comment may be
limited. If the number of individuals
wishing to pose a question or make a
comment is greater than can reasonably
be accommodated during the scheduled
meeting, the Commission may make a
random selection. Time permitting, we
will read aloud as many comments as
possible.
Anyone planning to attend the
meeting who needs special assistance,
such as sign language interpretation or
other reasonable accommodations,
should notify Esther Yoo by telephone
at (202) 795–7689, or email at
Esther.Yoo@bioethics.gov at least one
week in advance of the meeting. The
Commission will make every effort to
accommodate persons who need special
assistance.
Dated: July 8, 2016.
Lisa M. Lee,
Executive Director, Presidential Commission
for the Study of Bioethical Issues.
[FR Doc. 2016–17620 Filed 7–25–16; 8:45 am]
BILLING CODE 4154–06–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of General Medical
Sciences; Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
E:\FR\FM\26JYN1.SGM
26JYN1
]]>Agencies
[Federal Register Volume 81, Number 143 (Tuesday, July 26, 2016)]
[Notices]
[Page 48819]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-17620]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Public Meeting of the Presidential Commission for the Study of
Bioethical Issues
AGENCY: Presidential Commission for the Study of Bioethical Issues,
Office of the Assistant Secretary for Health, Office of the Secretary,
Department of Health and Human Services.
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: The Presidential Commission for the Study of Bioethical Issues
(the Commission) will conduct its twenty-sixth meeting on August 31,
2016. At this meeting, the Commission will reflect on the past,
present, and future impact of national bioethics advisory bodies.
Topics will include the history of national bioethics advisory bodies
and their contributions to health policy, perspectives about similar
bodies elsewhere, and discussion about what the future holds for groups
like the Commission.
DATES: The meeting will take place August 31, 2016, from 9 a.m. to
approximately 4 p.m.
ADDRESSES: Annenberg Public Policy Center, 202 S. 36th St.,
Philadelphia, PA 19104.
FOR FURTHER INFORMATION CONTACT: Lisa M. Lee, Executive Director,
Presidential Commission for the Study of Bioethical Issues, 330 C
Street SW., Suite L001, Washington, DC 20201. Telephone: 202-795-7689.
Email: Lisa.Lee@bioethics.gov. Additional information may be obtained
at www.bioethics.gov.
SUPPLEMENTARY INFORMATION: Pursuant to the Federal Advisory Committee
Act of 1972, Public Law 92-463, 5 U.S.C. app. 2, notice is hereby given
of the twenty-sixth meeting of the Commission. The meeting will be open
to the public with attendance limited to space available. The meeting
will also be webcast at www.bioethics.gov.
Under authority of Executive Order 13521, dated November 24, 2009,
the President established the Commission. The Commission is an expert
panel of not more than 13 members who are drawn from the fields of
bioethics, science, medicine, technology, engineering, law, philosophy,
theology, or other areas of the humanities or social sciences. The
Commission advises the President on bioethical issues arising from
advances in biomedicine and related areas of science and technology.
The Commission seeks to identify and promote policies and practices
that ensure scientific research, health care delivery, and
technological innovation are conducted in a socially and ethically
responsible manner.
The main agenda for the Commission's twenty-sixth meeting is to
reflect upon the role of national bioethics advisory bodies, both in
the US and abroad, in the past, present, and future.
The Commission welcomes input from anyone wishing to provide public
comment on any issue before it. Respectful consideration of opposing
views and active participation by citizens in public exchange of ideas
enhances overall public understanding of the issues at hand and
conclusions reached by the Commission. The Commission is particularly
interested in receiving comments and questions during the meeting that
are responsive to specific sessions. Written comments will be accepted
in advance, during, and after the meeting and are especially welcome.
Comments will be publicly available, including any personally
identifiable or confidential business information that they contain.
Trade secrets should not be submitted.
Written comments will be accepted by email to info@bioethics.gov,
or by mail to the following address: Public Commentary, Presidential
Commission for the Study of Bioethical Issues, 330 C Street SW., Suite
L001, Washington, DC 20201. To accommodate as many individuals as
possible, the time for each question or comment may be limited. If the
number of individuals wishing to pose a question or make a comment is
greater than can reasonably be accommodated during the scheduled
meeting, the Commission may make a random selection. Time permitting,
we will read aloud as many comments as possible.
Anyone planning to attend the meeting who needs special assistance,
such as sign language interpretation or other reasonable
accommodations, should notify Esther Yoo by telephone at (202) 795-
7689, or email at Esther.Yoo@bioethics.gov at least one week in advance
of the meeting. The Commission will make every effort to accommodate
persons who need special assistance.
Dated: July 8, 2016.
Lisa M. Lee,
Executive Director, Presidential Commission for the Study of Bioethical
Issues.
[FR Doc. 2016-17620 Filed 7-25-16; 8:45 am]
BILLING CODE 4154-06-P
